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Background: The 235delC mutation of GJB2 gene is considered as a risk factor for the non-syndromic hearing loss
(NSHL), and a significant difference in the frequency and distribution of the 235delC mutation has been described
world widely.
Methods: A systematic review was performed by means of a meta-analysis to evaluate the influence of the
235delC mutation on the risk of NSHL. A literature search in electronic databases using keywords “235delC”, “GJB2”
associated with “carrier frequency” was conducted to include all papers from January 1999 to June 2011. A total of
36 papers were included and there contained 13217 cases and 6521 controls derived from Oceania, American,
Europe and Asian.
Results: A remarkable heterogeneity between these studies was observed. The combined results of meta-analysis
showed that the 235delC mutant increased the risk of NSHL (OR= 7.9, 95%CI 4.77 ~ 13.11, P <0.00001). Meanwhile,
heterogeneity of genetic effect was also observed due to the ethnic specificity and regional disparity. Therefore, the
stratified meta-analysis was subsequently conducted and the results indicated that the 235delC mutation was
significantly correlated with the risk of NHSL in the East Asian and South-east Asian populations (OR= 12.05, 95%CI
8.33~17.44, P <0.00001), but not significantly in the Oceania and European populations (OR= 10.36, 95%CI:
4.68~22.96, Z= 1.68, P >0.05).
Conclusions: The 235delC mutation of GJB2 gene increased the risk of NHSL in the East Asian and South-east Asian
populations, but non-significantly associated with the NSHL susceptibility in Oceania and European populations,
suggesting a significant ethnic specificity of this NSHL-associated mutation.
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Hearing impairment is the most common sensory dis-
order, present in 1 of every 1000 newborns, about half of
which could be attributed to genetic factors [1]. There are
two monogenic forms of hearing loss including syndromic
(characterized by hearing loss in combination with other
abnormalities) and non-syndromic (with only hearing loss)
deafness [1]. Up to now, more than 70 loci for non-
syndromic hearing loss (NSHL) had been identified* Correspondence: caoxin@njmu.edu.cn; xing-gq@163.com
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reproduction in any medium, provided the or(http://hereditaryhearingloss.org/). Among them, DFNB1
was considered to be the main cause of prelingual deaf-
ness. As one of the DFNB1 locus-linked genes, GJB2 was
the first to be indentified which encoded the gap junction
protein connexin 26 (Cx26). To date, more than a hun-
dred different mutations of this gene has been impli-
cated in NSHL [2]. The most common mutations of
GJB2 gene comprised 35delG, 167delT and 235delC
with the varied incidence among populations [2].
The 235delC mutation of GJB2 is the most frequently
known mutation in some East Asian groups, with a car-
rier frequency of approximately 1% [3]. Recently, a sub-
stantial amount of research had been devoted to
elucidate the influence of this mutation on the risk of
NSHL, but conflicting results were obtained. Some stud-
ies reported that the 235delC mutation had only limited. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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that the 235delC mutation increased the risk of NSHL
or was concerned with the specificity pathological type
of NSHL [6, 7]. In those reported studies, the genetic
background of the ethnic specificity and the regional dis-
parity were not completely considered, or small effects
in human genetic association were difficult to be
detected due to small sample size of case-control stud-
ies. To clarify the variable results, a further research on
the association between ethnic specificity of the 235delC
mutation and the NSHL susceptibility was essentially
needed. In this study, a combined meta-analysis was per-
formed by pooling data from all relevant case-control
studies published in recent ten years. The association of
the 235delC mutation with hearing loss and the hetero-
geneity of genetic effect were evaluated, based on which
the stratified meta-analysis was subsequently conducted
to assess the ethnic specificity of the 235delC mutation
associated with the NSHL susceptibility.Methods
Literature search
The electronic databases including PubMed, Inter-
Science, British Library Direct, Embase, Sciencedirect,
Chinese Biomedical Literature, Chinese WanFangPotentiall
(36 pape
Excluded studies with incomplete data of case-contro
repeated data or unavailable papers (110 paper
 (24 pap




Excluded studies in South Asian, West Asian and N
Asian (5 papers) 
Figure 1 Flow chart of review process.database and China National Knowledge Infrastructure
were searched from January 1999 to June 2011, fulfilling
all case-control studies holding information on the epi-
demiology study in molecular genetics of hearing loss.
The following terms were used in search strategies:
GJB2, Connexin 26 (Cx26), mutation, variant, NSHL or
NSHI (non-syndromic hearing impairment). All related
citations were retrieved to find other relevant articles
that were not initially identified. The entire literature
search was performed by two independent researchers.Study selection
The reference lists of all traced articles were examined
manually and screened for eligibility using the following
criteria: (1) the association of the 235delC mutation of
GJB2 with NSHL was examined based on case-control
design; (2) the selected papers contained complete infor-
mation and represented Odds Ratio (OR) and 95% Con-
fidence Interval (95%CI) directly or indirectly; (3) for the
same studied populations, only the papers newly pub-
lished or providing the complete data were adopted. All
collected papers were scored and categorized according
to the Newcastle-Ottawa Scale (NOS) for assessing the
quality of case-control studies [8]. Studies with the low
score (below 6) or the genetic type of control groupy relevant publications identified and screened 
(146 papers) 
Publications included  
rs comprising 13217 cases and 6521 controls) 
l study, 
s) 
Publications included in Asian 
ers comprising 10160 cases and 3802controls) 
ns included in East Asian and Southeast Asian
pers comprising 9275cases and 2904controls) 
orth 
Table 1 235del mutation frequencies of of GJB2 allele in
the individual studies
No Relevant Studies TOTAL HETRO HOMO TOTAL%
1 Ohtsuka A, et al. 2003 [10] 1227 92 16 5.05%
2 Batissoco AC, et al. 2009 [11] 300 1 0 0.17%
3 Wattanasirichaigoon D,
et al. 2004 [12]
166 6 2 3.01%
4 Padma G, et al. 2009 [13] 456 0 1 0.22%
5 Park HJ, et al. 2000 [14] 147 5 5 5.10%
6 Shalin H, et al. 2002 [15] 48 0 1 2.08%
7 Lee KY, et al. 2008 [16] 29 0 2 6.90%
8 Schimmenti LA, et al. 2008 [17] 95 0 1 1.05%
9 Posukh O, et al. 2005 [18] 76 4 1 3.95%
10 Abe S, et al. 2000 [19] 35 4 1 8.57%
11 Tang, HY et al. 2006 [20] 610 1 0 0.08%
12 Tekin M, et al. 2010 [21] 534 12 2 1.50%
13 Kudo T, et al. 2000 [22] 63 1 3 5.56%
15 Cheng X, et al. 2005 [23] 740 1 1 0.20%
16 Wang YC, et al. 2002 [24] 169 6 8 6.51%
17 Chen D, et al. 2009 [25] 100 10 16 21.00%
18 Xiao ZA, et al. 2004 [26] 131 2 9 7.63%
19 Wang SH, et al. 2009 [27] 140 7 20 16.79%
20 Hwa, HL et al. 2003 [28] 324 16 11 5.86%
21 Shi GZ, et al. 2004 [29] 20 3 3 22.50%
22 Dai P, et al. 2007 [30] 3004 255 233 12.00%
23 Liu ZX, et al. 2002 [31] 118 20 14 20.34%
24 Liu YH, et al.2002 [32] 210 13 27 15.95%
(*χ2 = 6.667, P <0.05. A significant heterogeneity was found in the 235del
mutation frequency of GJB2 allele).
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librium (HWE) were categorized to Grade B, and the
others were categorized to Grade A [9].
Data extraction
A total of 146 papers were obtained through the search of
electronic databases. Among them, 36 papers associated
with the 235delC mutation of GJB2 gene and the NSHL
susceptibility were selected for the following data analysis.
The flow chart of review process was shown as Figure 1.
Data analysis
The mean value of carrier frequency of the 235delC mu-
tation in the individual studies was calculated. The
included populations were divided into two groups
(Asian and non-Asian groups) according to the distribu-
tion of carriers. The relationship between the 235delC
mutation of GJB2 and hearing loss was evaluated for
each group or continent. The statistical analysis was
conducted using Review Manager 5.1 (RevMan) supplied
by the Cochrane Collaboration (Oxford, UK). Hetero-
geneity among studies was assessed through Cochrane
χ2 test and I2 statistic (P< 0.05 indicating the existence
of between-study heterogeneity). Based on the test of
heterogeneity, the combined meta-analysis and stratified
meta-analysis were conducted respectively. The pooled
OR was calculated using fixed or random effect model,
along with the 95%CI to measure the strength of the
genetic association. The publication bias was analyzed
by STATA 11.0 and Begg’s test, and failsafe number (Nfs)
was calculated (Nfs> 10, P> 0.05 means that the
obtained conclusion was confident). The statistical ana-
lysis was performed using Software SPSS (Version 13,
Chicago, USA). An online tool (http://ihg.gsf.de/cgi-bin/
hw/hwa1.pl/) was applied to test whether the genetic
type of control group was consistent with Hardy-
Weinberg equilibrium (HWE) for each study.
Results
The 235delC carrier frequency of GJB2 allele
Among 36 included papers, there were 24 papers con-
taining the information on the 235delC carrier frequen-
cies of GJB2 allele, as shown in Table 1.
Characteristics of included studies
A total of 36 case-control studies comprising 13217
patients’ cases with NSHL and 6521 controls were
included in meta-analysis (Table 2). Each study was eval-
uated with a high score (not less than 5). Among them,
there were 14 papers categorized to Grade A. All the
included 36 case-control studies were consistent with
the Hardy-Weinberg Equilibrium test, indicating a good
representation of control populations.Meta-analysis of overall data
The 235delC mutation of GJB2 gene was not detected in
five case-control studies, so the rest of 31 studies com-
promising 12437 patients’ cases and 5844 controls were
included in meta-anslysis. The pooled OR was calculated
using random effect model, and the forest plot on the
association of mutation carriers with the risk of NSHL
was fulfilled (OR= 7.9, 95%CI: 4.77~13.11, Z= 8.01,
P<0.00001). As shown in Figure 2, the pooled OR and
95%CI values demonstrated that there was a higher
prevalence of the 235delC mutation in the case group
than in the control group. The publication bias was
examined by use of funnel plot (Figure 3). The visual in-
spection of funnel plot seemed to be symmetrical, and
most of the data points were located within 95%CI.
However, an absence of corner was observed possibly
due to the unpublished negative results. Additionally,
the Begg’s test was conducted to analyze the symmetry
of the funnel plot, and no significant publication bias
was found (Nfs = 58.84>10, P= 0.341>0.05), which
Table 2 Relevant studies on 235delC mutation and NSHL
No Author Score/ Grade No Author Score/ Grade
Studies in non-Asian populations
1 Dahl HM, et al. 2006 [4] 6A 7 Cheng X, et al. 2005 [23] 5B
2 Ramsebner R, et al. 2007 [5] 5B 8 Utrera R, et al. 2007 [33] 5B
3 Batissoco AC, et al. 2009 [11] 5B 9 Tang HY, et al. 2006 [20] 6A
4 Damalon V, et al. 2010 [34] 5B 10 Pollak A, et al. 2007 [35] 5B
5 Samanich J, et al. 2007 [36] 5B 11 Tóth T, et al. 2007 [37] 5B
6 Schimmenti LA, et al. 2008 [17] 6A 12 Neocleous V, et al. 2006 [38] 5B
Studies in East Asian and Southeast Asian populations
13 Snoeckx RL, et al. 2005 [39] 5B 23 Xiao ZA, et al. 2004 [26] 5B
14 Wattanasirichaigoon D, et al. 2004 [12] 5B 24 Wang SH, et al. 2009 [ 27] 6A
15 Park HJ, et al. 2000 [14] 6A 25 Hwa HL, et al. 2003 [28] 5B
16 Lee KY, et al. 2008 [16] 5B 26 Shi GZ, et al. 2004 [29] 6A
17 Abe S, et al. 2000 [19] 5B 27 Dai P, et al. 2007 [30] 6A
18 Ohtsuka A, et al. 2003 [10] 5B 28 Liu ZX, et al. 2002 [31] 5A
19 Tekin M , et al. 2010 [21] 5B 29 Liu YH, et al. 2002 [32] 6A
20 Kudo T, et al. 2000 [22] 5B 30 Chen GM, et al. 2011 [40] 5B
21 Wang YC, et al. 2002 [24] 6A 31 Guo YF, et al. 2008 [41] 6A
22 Chen D, et al. 2009 [25] 5B
Studies in South Asian, West Asian and North Asian populations
32 Padma G, et al. 2009 [13] 6A 35 Baysal E, et al. 2008 [42] 6A
33 Bhalla S, et al. 2009 [43] 6A 36 Posukh O, et al. 2005 [18] 5B
34 Shalin H, et al. 2002 [15] 5B
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the result of meta-analysis and the conclusions obtained
were confident.
Heterogeneity of genetic effect was detected as shown
in Figure 2 (χ2 = 56.12, df= 30, P= 0.003<0.05, I2= 47%),
which indicated that the association of the 235delC mu-
tation with the risk of NSHL was varied due to the eth-
nic specificity or regional disparity. To elucidate the
prevalence of the 235delC mutation related to the NSHL
susceptibility more precisely, the stratified meta-analysis
was subsequently performed according to the regional
studies. It was observed that a high prevalence of the
235delC mutation related to hearing loss was reported
in Asian (Figure 4). Therefore, the populations of the
included studies were divided into Asian and Non-Asian
population groups, and the stratified meta-analysis was
conducted to each group.
Stratified meta-analysis of Asian population group
Two studies were excluded due to undetectable 235delC
mutations in patients’ cases or incomplete statistical data
in controls. And a total of 22 papers compromising 9855
patients’ cases and 3634 controls were included in the
stratified meta-analysis. The pooled OR was calculated
using random effect model, and forest plot on theassociation of mutation carriers with the risk of NSHL
was fulfilled (OR= 8.95, 95%CI: 5.44 ~ 14.73,
Z= 8.62, P< 0.00001). As shown in Figure 5, the pooled
OR and 95%CI values demonstrated that the 235delC
mutation of GJB2 gene was significantly associated
with the risk of NSHL in Asian population. The visual
inspection of funnel plot seemed to be symmetrical
(Figure 6), and most of the data points were located
within 95%CI. The Begg’s test was also used to analyze
the symmetry of funnel plot, and no significant publica-
tion bias was found (Nfs = 35.46>10, P= 0.499>0.05),
which suggested that and the publication bias had little
effect on the result of meta-analysis and the conclusions
obtained were confident.
Heterogeneity of genetic effect was still detected as
shown in Figure 5 (χ2 = 33.90, df= 21, P= 0.04<0.05,
I2= 38%), which demonstrated the presence of disparity
in the prevalence of the 235delC mutation related to
NSHL susceptibility among Asian populations suggest-
ing the need of further stratified meta-analysis.
Stratified Meta-analysis of East Asian and Southeast Asian
populations
The overall effect on included studies in East Asian and
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Heterogeneity: Tau² = 0.80; Chi² = 56.12, df = 30 (P = 0.003); I² = 47%
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Figure 2 Forest plot on the association of 235delC mutation with the risk of NSHL.
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cases and 2904 controls. The forest plot on the associ-
ation of mutation carriers with the risk of NSHL was
fulfilled using random effect model (OR= 12.05, 95%CI:
8.33 ~ 17.44, Z= 13.21, P <0.00001). As shown in
Figure 7, the pooled OR and 95%CI values demonstra-
ted that the prevalence of the 235delC mutation washigher in the case group than in the control group.
Publication bias was examined by use of funnel plot
(Figure 8). The Begg’s test was also used to analyze
the symmetry of funnel plot, and no significant publi-
cation bias was found (Nfs = 28.58>10, P= 0.576>0.05),
which suggested that and the publication bias had little









Standard error of log odds ratio 
Figure 3 Begg’s funnel plot assessing publication bias on all
included studies.
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heterogeneity of genetic effect was found as shown in
Figure 7 (χ2 = 27.16, df= 18, P= 0.08>0.05, I2= 34%).
The above analytic results indicated that the 235delC
mutation of GJB2 gene was significantly associated with
the risk of NSHL in East Asian and Southeast Asian.
Due to the insufficient searched studies, the meta-
analysis was not performed to the regional studies in
North Asian, West Asian and South Asian populations,
respectively.
Stratified Meta-analysis of Non-Asian population group
(Europe and Oceania populations)
Three case-control studies were excluded due to no
235delC mutation of GJB2 gene detected, and a total of
9 papers were included, compromising 2683 patients’
cases and 2397 controls. The pooled OR was calculatedEast Asia, 10203, 52%
Figure 4 Proportions of tested individuals in different continents.using random effect model, and forest plot on the asso-
ciation of mutation carriers with the risk of NSHL was
fulfilled (Figure 9). The prevalence of the 235delC muta-
tion seemed to be ethnic-specific, but was not signifi-
cantly associated with the NSHL susceptibility in
European and Oceania population (OR= 10.36, 95%CI:
4.68 ~ 22.96, Z= 1.68, P= 0.09>0.05).
Discussion
The investigation on heterogeneity in genetic association
were commonly leveled to the genetic effect and genetic
model: the genetic effect focused on the difference in
study method, potential interaction of gene-gene or
gene-environment and linkage disequilibrium [13], while
the genetic model was mainly concerned with the differ-
ential association between heterozygote (or homozygote)
and the risk of human diseases. The development of
hearing loss involved with numerous factors and experi-
enced multiple steps, and the interaction of heredity
(genes) and environmental factors played an important
role, which could have a potential influence on the asso-
ciation of GJB2 mutations and the NSHL susceptibility
with ethnic specificity or certain genetic backgrounds of
affected families. Meanwhile, the same type of single nu-
cleotide polymorphisms (SNP) could show various con-
tributions to the genetic models derived from different
studies due to the ethnic specificity.
By increasing the sample size, meta-analysis based on
case-control studies has the potential to evaluate the
between-study heterogeneity and detect small effects in
genetic association. In this study, the combined results of
meta-analysis showed that the 235delC mutant increased
the risk of NSHL, but significant between-study hetero-
geneity and genetic-effect heterogeneity were detected, in-
dicating that the ethnic specificity and regional disparityOceania, 458, 2%
South America, 776, 4%
North Asia, 206, 1%
Southeast Asia, 1952, 10%
West Asia, 610, 3%
South Asia, 967, 5%
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Figure 6 Begg’s funnel plot assessing publication bias on
included studies in Asian populations.
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tion of GJB2 gene and the NSHL susceptibility. Results of
stratified meta-analysis showed that the 235delC mutation
was prominently associated with the risk of NSHL in East
Asian and Southeast Asian populations, but not signifi-
cantly in European and Oceania populations. The 235delC
mutation of GJB2 gene trended to be consistent with re-
cessive model in Chinese population, while heterogeneity
of genetic effect was also detected in studies of GJB2 mu-
tation reported in Europe and Oceania, which suggested
that multiple models could possibly be present in Euro-
pean and American populations, due to a complex inter-
action between GJB2 mutations and environmental
factors. A further research on the prevalence of the
235delC mutation of GJB2 gene related to the NSHL sus-
ceptibility, as well as the regional disparity and ethnic spe-
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Figure 7 Forest plot on the association of 235delC mutation with the risk of NSHL in East Asian and Southeast Asian populations.
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A systematic review was performed by means of a meta-
analysis to evaluate the influence of the 235delC muta-








Standard error of log odds ratio 
Figure 8 Begg’s funnel plot assessing publication bias on
included studies in East Asian and Southeast Asian
populations.of meta-analysis by pooling all relevant studies showed
that the 235delC mutant increased the risk of NSHL.
However, heterogeneity of genetic effect was observed
due to the ethnic specificity and regional disparity.
Therefore, stratified meta-analysis was conducted in dif-
ferent ethnic population group, and the results indicated
that the 235delC mutation was prominently correlated
with the risk of NHSL in the East Asian and South-east
Asian populations, but non-significantly associated with
the Oceania and European populations. Based on this
study, a further research on the genetic mechanism of
the NSHL susceptibility related to the 235delC mutation
of GJB2 gene will be carried out in our future work.Competing interests
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Figure 9 Forest plot on the association of 235delC mutation with the risk of NSHL in Europe and Oceania populations.
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